These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Role of interventional radiology in managing pediatric liver tumors : Part 1: Endovascular interventions. Lungren MP; Towbin AJ; Roebuck DJ; Monroe EJ; Gill AE; Thakor A; Towbin RB; Cahill AM; Matthew Hawkins C Pediatr Radiol; 2018 Apr; 48(4):555-564. PubMed ID: 29362840 [TBL] [Abstract][Full Text] [Related]
4. Loco-regional treatment of hepatocellular carcinoma in the era of molecular targeted therapies. Lencioni R Oncology; 2010 Jul; 78 Suppl 1():107-12. PubMed ID: 20616592 [TBL] [Abstract][Full Text] [Related]
6. New concepts in embolotherapy of HCC. Pesapane F; Nezami N; Patella F; Geschwind JF Med Oncol; 2017 Apr; 34(4):58. PubMed ID: 28299645 [TBL] [Abstract][Full Text] [Related]
7. Frontiers of therapy for hepatocellular carcinoma. Heller M; Parikh ND; Fidelman N; Owen D Abdom Radiol (NY); 2021 Aug; 46(8):3648-3659. PubMed ID: 33837453 [TBL] [Abstract][Full Text] [Related]
8. Combination of interventional therapies in hepatocellular carcinoma. Lencioni R; Cioni D; Donati F; Bartolozzi C Hepatogastroenterology; 2001; 48(37):8-14. PubMed ID: 11269005 [TBL] [Abstract][Full Text] [Related]
9. Treatment of hepatocellular carcinoma combining sorafenib and transarterial locoregional therapy: state of the science. Weintraub JL; Salem R J Vasc Interv Radiol; 2013 Aug; 24(8):1123-34. PubMed ID: 23562168 [TBL] [Abstract][Full Text] [Related]
11. Management of Hepatocellular Carcinoma: Current Status and Future Directions. Au JS; Frenette CT Gut Liver; 2015 Jul; 9(4):437-48. PubMed ID: 26087860 [TBL] [Abstract][Full Text] [Related]
12. Loco-regional interventional treatment of hepatocellular carcinoma: techniques, outcomes, and future prospects. Lencioni R; Crocetti L; De Simone P; Filipponi F Transpl Int; 2010 Jul; 23(7):698-703. PubMed ID: 20492618 [TBL] [Abstract][Full Text] [Related]
13. Transcatheter chemoembolization of unresectable hepatocellular carcinoma: current knowledge and future directions. Maleux G; van Malenstein H; Vandecaveye V; Heye S; Vaninbroukx J; Nevens F; Verslype C Dig Dis; 2009; 27(2):157-63. PubMed ID: 19546554 [TBL] [Abstract][Full Text] [Related]
14. Interventional oncology for hepatocellular carcinoma. Delicque J; Boulin M; Guiu B; Pelage JP; Escal L; Schembri V; Assenat E; Fohlen A Clin Res Hepatol Gastroenterol; 2016 Nov; 40(5):530-537. PubMed ID: 27055387 [TBL] [Abstract][Full Text] [Related]
15. Noncontrast chest computed tomography immediately after transarterial chemoembolization in patients with hepatocellular carcinoma: clinical benefits and effect of radiation reduction on image quality in low-dose scanning. Choi JI; Kim HB; Kim MJ; Lee JS; Koh YW; An SB; Ko HK; Park JW Eur J Radiol; 2011 Nov; 80(2):e188-94. PubMed ID: 21708441 [TBL] [Abstract][Full Text] [Related]
16. Role of interventional oncology for treatment of liver metastases: evidence based best practice. Stavrovski T; Pereira P Br J Radiol; 2022 Sep; 95(1138):20211376. PubMed ID: 35976260 [TBL] [Abstract][Full Text] [Related]
17. Emerging Trends in the Treatment of Advanced Hepatocellular Carcinoma: A Radiological Perspective. Kim GH; Kim JH; Kim PH; Chu HH; Gwon DI; Ko HK Korean J Radiol; 2021 Nov; 22(11):1822-1833. PubMed ID: 34431250 [TBL] [Abstract][Full Text] [Related]
18. Three-dimensional rotational angiography: introduction of an adjunctive tool for successful transarterial chemoembolization. Liapi E; Hong K; Georgiades CS; Geschwind JF J Vasc Interv Radiol; 2005 Sep; 16(9):1241-5. PubMed ID: 16151066 [TBL] [Abstract][Full Text] [Related]